专利号:WO-2009003796-A1 优先权日:2007-06-29 标 题:Method for the synthesis of neral by the isomerization of isocitrals 发明人:SCHMIDT-LEITHOFF JOACHIM; JAEKEL CHRISTOPH; PACIELLO ROCCO; HEYDRICH GUNNAR; HEIDEMANN THOMAS 权利人:BASF SE; SCHMIDT-LEITHOFF JOACHIM; JAEKEL CHRISTOPH; PACIELLO ROCCO; HEYDRICH GUNNAR; HEIDEMANN THOMAS 摘要:The present invention relates to a method for the synthesis of neral and/or geranial by the isomerization of one or more isocitrals. In particular, the invention relates to a method for the synthesis of neral in pure or enriched form, starting out from a mixture of materials containing neral and geranial and one or more isocitrals.
专利号:US-4064150-A 优先权日:1976-05-26 标 题 :Synthesis of isoprenoid 1,5-dienes 发明人:KATZENELLENBOGEN JOHN A 权利人:UNIV ILLINOIS 摘要:Aliphatic acids containing an isoprenoid 1,5-diene moiety are prepared in high yields by the selective gamma alkylation of α,β-unsaturated acids with allylic electrophiles. The gamma-regioselectivity of the alkylation is controlled by the use of the dicopper(I) dienolates prepared from the α,β-unsaturated acids. The method offers a particularly facile means for synthesizing isoprenoid 1,5-diene natural products such as farnesoic acid by alkylation of senecioic acid with geranyl bromide; geranoic acid by alkylation of senecioic acid with 3,3-dimethallyl bromide; and dl-lanceol by alkylation of tiglic acid with an allylic bromide derived from dl-limonene. Such products find use in the synthesis of insect pheremones, insect juvenile hormones, and components of perfumes.
专利号:US-2018105838-A1 优先权日:2015-03-11 标 题:Process for de novo microbial synthesis of terpenes 发明人:SCHRADER JENS; BUCHHAUPT MARKUS; SONNTAG FRANK; KRONER CORA; BRÜSER HEIKE; Schröder Hartwig; PELZER RALF 权利人:BASF SE 摘要:The invention relates to microbial terpene production. Known methods for microbial production of terpenes are mostly based on the direct conversion of sugars. Therefore alternative substrates, in particular alternative carbon sources, for use in microbial terpene production were desirable. The invention relates to a methylotrophic bacterium containing recombinant DNA coding for at least one polypeptide with enzymatic activity for heterologous expression in said bacterium, wherein said at least one polypeptide with enzymatic activity is selected from the group consisting an enzyme of a heterologous mevalonate pathway, a heterologous terpene synthase and optionally a heterologous synthase of a prenyl diphosphate precursor. The invention further relates in particular to a method for de novo microbial synthesis of sesquiterpenes or diterpenes from methanol and/or ethanol.
专利号:WO-2023247609-A1 优先权日:2022-06-22 标题 :Process for the preparation of cyclohomogeranates 发明人:SCHELWIES MATHIAS; BRUNNER BERNHARD; PELZER RALF; LIST BENJAMIN; TURBERG MATHIAS; MITSCHKE BENJAMIN; DAS SAYANTANI; DE CHANDRA KANTA 权利人:BASF SE; STUDIENGESELLSCHAFT KOHLE GGMBH 摘要:The present invention relates to a process for the preparation of cyclohomogeranates. The invention relates to the synthesis of cyclohomogeranates from well available esters of homogeranic acid in only one step. The cyclohomogeranates prepared according to the process of the present invention can be used in the fragrance industry as intermediates or the compounds can be used as such as aroma compound.
专利号:US-2022356497-A1 优先权日:2019-06-26 标 题 :Compositions and methods for synthesis of terpenoids 发明人:DE KOK STEFAN; LAU WARREN; MCSORLEY FERN; MEYER HERMANN-JOSEF; SERBER ZACH; WAWRZYN GRAYSON 权利人:ZYMERGEN INC 摘要:The disclosure relates to the biosynthesis of terpenoids, such as, for example, geraniol and derivatives thereof, using genetic engineering. In particular, the disclosure relates to the biosynthesis of nepetalactol, nepetalactone, dihydronepetalactone, and derivatives thereof. The disclosure provides recombinant cells genetically engineered to produce high levels of nepetalactol, nepetalactone and/or dihydronepetalactone. The disclosure also provides methods of producing nepetalactol, nepetalactone and dihydronepetalactone using cell-based systems as well as cell-free systems.
专利号:WO-2024227949-A1 优先权日:2023-05-04 标 题:Screening and uses of glutamine synthetase modulators 发明人:MARTINS GARCIA BRUNA; FARAH PERNAS LENA 权利人:MAX PLANCK GESELLSCHAFT 摘要:The present invention relates to an in vitro bioassay to identify glutamine synthetase activators and inhibitors on the basis of one or more glutamine markers such as citrate, a metabolite derived from the mevalonate pathway, a glutamine responsive mRNA or proteins, such as HMGCR or SREBP2. Disclosed herein are also glutamine synthetase activators and inhibitors identified by the inventive method for use to stimulate or inhibit the synthesis of a metabolite derived from the mevalonate pathway, such as cholesterol, and to treat a disease associated with deregulated levels of said metabolite, such as cancer.
1: Tanner EEL, Curreri AM, Balkaran JPR, Selig-Wober NC, Yang AB, Kendig C, Fluhr MP, Kim N, Mitragotri S. Design Principles of Ionic Liquids for Transdermal Drug Delivery. Adv Mater. 2019 Jul;31(27):e1901103. doi: 10.1002/adma.201901103. Epub 2019 May 21. doi: 10.1021/acs.jafc.8b04395. Epub 2018 Nov 12. doi: 10.1016/j.fct.2018.08.022. Epub 2018 Aug 16. Review. doi: 10.1016/j.jconrel.2018.07.029. Epub 2018 Jul 17. doi: 10.1073/pnas.1722338115. Epub 2018 Jun 25. 6: Kries H, Kellner F, Kamileen MO, O'Connor SE. Inverted stereocontrol of iridoid synthase in snapdragon. J Biol Chem. 2017 Sep 1;292(35):14659-14667. doi: 10.1074/jbc.M117.800979. Epub 2017 Jul 12. 7: Haruehanroengra P, Vangaveti S, Ranganathan SV, Wang R, Chen A, Sheng J. Nature's Selection of Geranyl Group as a tRNA Modification: The Effects of Chain Length on Base-Pairing Specificity. ACS Chem Biol. 2017 Jun 16;12(6):1504-1513. doi: 10.1021/acschembio.7b00108. Epub 2017 Apr 18. doi: 10.1038/ncomms11035.
合成参考文献
摘要:Hollmann, F., Science of Synthesis: Biocatalysis in Organic Synthesis, (2015) 3, 122. 摘要:Biochemical Journal., 34(1196), 1940 参考文献:10.1016/s0960-894x(02)00038-0 摘要:Kim S, Kim E, Shin DS, Kang H, Oh KB. Evaluation of morphogenic regulatory activity of farnesoic acid and its derivatives against Candida albicans dimorphism. Bioorg Med Chem Lett. 2002 Mar 25;12(6):895–8. doi: 10.1016/s0960-894x(02)00038-0. 参考文献:10.1007/s00253-020-10811-9 摘要:Weimer A, Kohlstedt M, Volke DC, Nikel PI, Wittmann C. Industrial biotechnology of Pseudomonas putida: advances and prospects. Applied Microbiology and Biotechnology. 2020 Aug 13;104(18):7745–66. doi: 10.1007/s00253-020-10811-9.